ArticleCancer reports (Hoboken, N.J.)2022

Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast-enhanced ultrasound.

Naoki Kamachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.